Trademark: 79398160
Word
SANWAY GENE
Status
Pending
Status Code
641
Status Date
Saturday, August 17, 2024
Serial Number
79398160
Mark Type
3
Filing Date
Friday, January 5, 2024

Trademark Owner History

Classifications
5 Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, infectious disease, viral disease, inflammatory disorders, dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastroenterological disorders; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes; reagents for use in medical genetic testing; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; demineralised water for medical purposes; diagnostic kits comprised of medical diagnostic reagents for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting the diseases related to the cancer, infectious diseases, viral disease, hereditary disease, inflammatory disorders, and oncological disorders of digestive system, blood system, reproductive system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for the diagnosis of disorders of digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, cancer, hereditary disease, infectious disease, viral disease, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biological preparations for the treatment of disorders of digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, cancer, hereditary disease, infectious disease, viral disease, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the diagnosis of disorders of digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, cancer, infectious disease, viral disease,hereditary disease, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the treatment of disorders of digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, cancer, infectious disease, viral disease,hereditary disease, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; antibiotic tablets; allergy tablets; chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary disease, viral disease, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary disease, viral disease, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposes.
10 Surgical apparatus and instruments; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for immunoassay, apparatus for cavitation detecting, and apparatus for imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus, for use with computer displays, computer monitors and for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; genetic testing apparatus for medical purposes; medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for testing DNA and RNA samples; genetic testing apparatus for medical purposes.
The mark consists of a stylized DNA double-helix inside a square background, and to the right of the design is the stylized word "SANWAY" and "GENE" with four Chinese characters arranged in two lines.
The non-Latin characters in the mark transliterate to "Sheng Wei Ji Yin"  and this means "holy dimension gene" in English.
"GENE" and the non-Latin Characters that transliterate to "JI YIN"

Trademark Events
Jun 20, 2024
Sn Assigned For Sect 66a Appl From Ib
Jun 28, 2024
Limitation From Original Application Entered
Jul 2, 2024
New Application Office Supplied Data Entered
Jul 2, 2024
Application Filing Receipt Mailed
Aug 7, 2024
Non-Final Action Written
Aug 1, 2024
Assigned To Examiner
Aug 8, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Aug 17, 2024
Refusal Processed By Mpu
Sep 9, 2024
Refusal Processed By Ib
Aug 19, 2024
Non-Final Action Mailed - Refusal Sent To Ib

Trademark Alertz updated from USPTO on 2030-01-24